ARCHIVES

In Their Own Words: A 64-page Internal Report with over 1,500 Faculty Comments on MD Anderson Morale

This article is from The Cancer Letter archive.

Vol. 39 No. 13 | March 29, 2013

Download PDF Visit The Full Archive

Related Articles

Surgery Lowers Risk By 90% In Women With Gene Mutations

April 30, 2004

Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival

September 28, 2012

Pilot Projects Scheduled To Begin Next Summer

December 4, 1998

NKTR-102 Shows 29 Percent Response in Phase II Study

September 30, 2011

Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study

December 26, 2014

$150 Mil. For Army Breast Cancer Program Urged In Letter

September 16, 1994